#b#Novo Nordisk#/b#, a developer of diabetes medicines based on Route 1, care, announced that it has awarded $165,000 in scholarships and capital improvement funds to diabetes summer camps at fifteen locations nationwide. Among the recipients is Camp Nejeda, the only residential summer camp in New Jersey and its neighboring states serving exclusively youth with insulin dependent diabetes and their families.

Facebook Comments